In an elderly nursing home resident with dementia and anxiety who has been taking fluoxetine 20 mg daily and lorazepam (Ativan) 0.5 mg twice daily for several years and now presents with worsening confusion and somatic preoccupations, what is the best treatment?

Discontinue Lorazepam Immediately and Taper Fluoxetine

The best treatment is to discontinue lorazepam (Ativan) immediately given its strong association with worsening confusion, cognitive impairment, and paradoxical agitation in elderly patients with dementia, and to taper fluoxetine given its potential contribution to cognitive dysfunction and somatic preoccupations. 1, 2, 3, 4

Critical Problem: Chronic Benzodiazepine Use in Dementia

This patient's worsening confusion is most likely iatrogenic. Benzodiazepines like lorazepam cause tolerance, addiction, depression, and cognitive impairment with regular use, and paradoxical agitation occurs in approximately 10% of patients 2. In elderly patients with dementia specifically:

• Lorazepam can produce drug-induced pseudodementia that mimics true dementia progression 4
• Benzodiazepines are associated with the highest risk of adverse outcomes including falls, cognitive worsening, and mortality compared to other psychotropic medications 5
• The FDA label explicitly warns that lorazepam causes sedation, cognitive impairment, and withdrawal symptoms, with particular caution in elderly patients 3
• Recent 2025 evidence shows midazolam (another benzodiazepine) had the highest adverse event rate (53%) in older adults with agitation, with benzodiazepines posing "excessive risk" 6

Fluoxetine's Contribution

Fluoxetine at 20mg daily for several years may be contributing to:

• Memory loss and cognitive dysfunction, particularly in elderly patients 7, 8
• Somatic preoccupations and obsessive symptoms through serotonergic effects
• The combination with chronic lorazepam creates polypharmacy-related cognitive burden 1, 9

Immediate Management Algorithm

Step 1: Discontinue Lorazepam

• Stop lorazepam immediately - the 0.5mg BID dose is low enough that abrupt discontinuation is reasonable in this context 2, 4
• Monitor for benzodiazepine withdrawal (anxiety, tremor, seizures) over 48-72 hours, though unlikely at this dose
• Expect cognitive improvement within 2 weeks, with full resolution by 4 weeks 4, 8

Step 2: Address Reversible Causes of Confusion

Before making further medication changes, evaluate for 10, 11:

• Urinary retention or urinary tract infection
• Constipation (common with chronic medications)
• Pain (may manifest as agitation in dementia)
• Hypoxia or metabolic derangements

Step 3: Taper Fluoxetine

After lorazepam discontinuation and once reversible causes are addressed:

• Reduce fluoxetine by 10mg every 2 weeks (discontinue over 10-14 days per guidelines) 2
• Monitor for withdrawal symptoms and worsening depression
• Reassess need after 9 months of any antidepressant therapy per guidelines 2

Step 4: Non-Pharmacologic Interventions First

For ongoing anxiety and behavioral symptoms 11, 12:

• Person-centered communication and orientation
• Structured daily routines
• Address environmental triggers
• Caregiver education and support
• These must be attempted before considering any new psychotropic medications

If Severe Agitation Requires Pharmacologic Treatment

Only if symptoms are severe, dangerous, or cause significant distress after non-pharmacologic interventions fail 11:

For Anxiety Without Psychosis:

• Avoid benzodiazepines entirely 13, 6
• Consider buspirone 5mg BID, titrating slowly (useful only for mild-moderate agitation, takes 2-4 weeks) 2
• Trazodone 25mg daily, maximum 200-400mg divided (better tolerated mood stabilizer) 2

For Severe Agitation With Psychosis:

• Low-dose atypical antipsychotic only as last resort (risperidone 0.25-0.5mg, quetiapine 12.5-25mg) 11
• FDA black box warning: increased mortality risk in dementia patients 1
• Start at lowest dose, titrate slowly, reassess after 4 weeks 11
• Attempt taper every 3-6 months 11

Common Pitfalls to Avoid

1. Do not substitute another benzodiazepine - all carry similar risks in elderly patients with dementia 2, 13, 6
2. Do not add anticholinergic medications - will worsen confusion 2, 1, 9
3. Do not assume worsening confusion is dementia progression - it may be entirely drug-induced and reversible 4, 9
4. Do not continue fluoxetine indefinitely without reassessment - guidelines recommend periodic dose reduction to evaluate ongoing need 2
5. Do not start antipsychotics without documented trial of non-pharmacologic interventions 11, 12

Expected Timeline

• Days 1-3: Lorazepam discontinued, monitor for withdrawal
• Week 1-2: Begin seeing cognitive improvement from lorazepam cessation 4
• Week 2-4: Start fluoxetine taper if patient stable
• Week 4-8: Expect full cognitive recovery if drug-induced 4, 8
• Ongoing: Maintain non-pharmacologic interventions, avoid reintroducing benzodiazepines

The evidence strongly supports that this patient's worsening confusion is iatrogenic from chronic benzodiazepine use, potentially compounded by fluoxetine. Deprescribing these medications with appropriate monitoring should result in significant cognitive improvement without requiring new psychotropic medications.